Paul R. Kirchgraber

2020

In 2020, Paul R. Kirchgraber earned a total compensation of $3M as Executive Vice President, Chief Executive Officer, Drug Development at Laboratory Corp. of America Holdings.

Compensation breakdown

Non-Equity Incentive Plan$724,608
Option Awards$292,210
Salary$606,000
Stock Awards$1,283,873
Other$66,960
Total$2,973,651

Kirchgraber received $1.3M in stock awards, accounting for 43% of the total pay in 2020.

Kirchgraber also received $724.6K in non-equity incentive plan, $292.2K in option awards, $606K in salary and $67K in other compensation.

Rankings

In 2020, Paul R. Kirchgraber's compensation ranked 3,884th out of 13,090 executives tracked by ExecPay. In other words, Kirchgraber earned more than 70.3% of executives.

ClassificationRankingPercentile
All
3,884
out of 13,090
70th
Division
Services
840
out of 2,338
64th
Major group
Health Services
84
out of 252
67th
Industry group
Medical And Dental Laboratories
25
out of 73
66th
Industry
Medical Laboratories
25
out of 73
66th

Pay ratio

Paul R. Kirchgraber's Pay$2,973,651
Median Employee's Pay$41,670
Pay Ratio

71

to 1

In 2020, the annual total compensation of Paul R. Kirchgraber was $2,973,651.

The annual total compensation of the median employee at Laboratory Corp. of America Holdings was $41,670.

The ratio of Paul R. Kirchgraber's pay to the pay of median employee was therefore 71 to one.

Source: SEC filing on April 2, 2021.

Kirchgraber's colleagues

We found four more compensation records of executives who worked with Paul R. Kirchgraber at Laboratory Corp. of America Holdings in 2020.

2020

Adam Schechter

Laboratory Corp. of America Holdings

Chief Executive Officer

2020

GLENN EISENBERG

Laboratory Corp. of America Holdings

Chief Financial Officer

2020

Mark Schroeder

Laboratory Corp. of America Holdings

Executive Vice President, President Diagnostics, Laboratory Operations and Global Supply Chain

2020

Brian Caveney

Laboratory Corp. of America Holdings

Chief Medical Officer

News

You may also like